Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [ 11C]-acetate PET during radiotherapy: Preliminary results

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 554-560

  Sun, Aijun ^a,b   Johansson, Silvia ^a   Turesson, Ingela ^a   Dau, Alexandru ^b   Sörensen, Jens ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1 11C acetate PET; Head and neck cancer; Oxidative metabolism; Perfusion; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE; GLUCOSE UPTAKE; HEAD-AND-NECK CANCER; IN-VITRO; IN-VIVO; INTERMEDIARY METABOLISM; METABOLIC RATES; OXIDATIVE METABOLISM; PERFUSION; TREATMENT OUTCOMES; TUMOR PERFUSION;

DISEASES; GLUCOSE; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS; VOLATILE FATTY ACIDS;

METABOLISM;

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; GLUCOSE TRANSPORT; HEAD AND NECK CANCER; HUMAN; MALE; METABOLIC RATE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TUMOR BLOOD FLOW;

ACETIC ACID; ADOLESCENT; AGED; CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLYCOLYSIS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; RADIATION TOLERANCE; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; REGIONAL BLOOD FLOW; REMISSION INDUCTION;

EID: 84855832247     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.007     Document Type: Article

References (31)

1. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
2. I.J. Hoogsteen, H.A. Marres, and J. Bussink Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A review Head Neck 29 2007 591 604
3. B. Vanselow, M.J. Eble, and V. Rudat Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy Otolaryngol Head Neck Surg 122 2000 856 862
4. J.H. Eric, and J.G. Amato Radiobiology for radiologist 6th ed 2006 Lippincott Williams & Wilkins Philadelphia, PA
5. R. Moreno-Sanchez, S. Rodriguez-Enriquez, and A. Marin-Hernandez Energy metabolism in tumor cells FEBS J 274 2007 1393 1418
6. O. Warburg On respiratory impairment in cancer cells Science 124 1956 269 270
7. K. Soderberg, E. Nissinen, and B. Bakay The energy charge in wild-type and respiration-deficient Chinese hamster cell mutants J Cell Physiol 103 1980 169 172
8. M. Ristow Oxidative metabolism in cancer growth Curr Opin Clin Nutr Metab Care 9 2006 339 345
9. W.A. Weber Positron emission tomography as an imaging biomarker J Clin Oncol 24 2006 3282 3292
10. S. Basu, and A. Alavi Staging with PET and the "Will Rogers" effect: Redefining prognosis and survival in patients with cancer Eur J Nucl Med Mol Imaging 35 2008 1 4
11. B. Gagel, M. Piroth, and M. Pinkawa pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: Validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer 7 2007 113
12. M.A. Brown, D.W. Myears, and S.R. Bergmann Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization J Nucl Med 30 1989 187 193
13. J.J. Armbrecht, D.B. Buxton, and R.C. Brunken Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography Circulation 80 1989 863 872
14. S.Y. Chan, R.C. Brunken, and M.E. Phelps Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion J Nucl Med 32 1991 665 672
15. B. Mittendorfer, L.S. Sidossis, and E. Walser Regional acetate kinetics and oxidation in human volunteers Am J Physiol 274 1998 E978 E983
16. C.L. Ho, S.C. Yu, and D.W. Yeung 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses J Nucl Med 44 2003 213 221
17. G. Sandblom, J. Sorensen, and N. Lundin Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy Urology 67 2006 996 1000
18. A. Sun, J. Sorensen, and M. Karlsson 1-[11C]-acetate PET imaging in head and neck cancera comparison with 18F-FDG-PET: Implications for staging and radiotherapy planning Eur J Nucl Med Mol Imaging 34 2007 651 657
19. B.R. Pflug, S.M. Pecher, and A.W. Brink Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model Prostate 57 2003 245 254
20. P. Therasse Evaluation of response: New and standard criteria Ann Oncol 13 Suppl 4 2002 127 129
21. S. Zhou, S. Kachhap, and W. Sun Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck Proc Natl Acad Sci U S A 104 2007 7540 7545
22. I. Papandreou, R.A. Cairns, and L. Fontana HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab 3 2006 187 197
23. F. Lopez-Rios, M. Sanchez-Arago, and E. Garcia-Garcia Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas Cancer Res 67 2007 9013 9017
24. S.D. Silva, M. Agostini, and I.N. Nishimoto Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study Oral Oncol 40 2004 688 696
25. C. van Waveren, Y. Sun, and H.S. Cheung Oxidative phosphorylation dysfunction modulates expression of extracellular matrixremodeling genes and invasion Carcinogenesis 27 2006 409 418
26. J.J. Armbrecht, D.B. Buxton, and H.R. Schelbert Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium Circulation 81 1990 1594 1605
27. L. Juillard, S. Lemoine, and M.F. Janier Validation of renal oxidative metabolism measurement by positron-emission tomography Hypertension 50 2007 242 247
28. L.J. Klein, F.C. Visser, and P. Knaapen Carbon-11 acetate as a tracer of myocardial oxygen consumption Eur J Nucl Med 28 2001 651 668
29. L.L. Ponto, M.T. Madsen, and R.D. Hichwa Assessment of blood flow in solid tumors using PET Clin Positron Imaging 1 1998 117 121
30. G.R. Laking, C. West, and D.L. Buckley Imaging vascular physiology to monitor cancer treatment Crit Rev Oncol Hematol 58 2006 95 113
31. O. Lindhe, A. Sun, and J. Ulin [(18)F]Fluoroacetate is not a functional analogue of [(11)C]acetate in normal physiology Eur J Nucl Med Mol Imaging 36 2009 1453 1459